Skip to main content
SpringerLink
Log in

Interferon-γ (IFN-γ) and interleukin-2 in the generation of lymphokine-activated killer cell cytotoxicity — IFN-γ-induced suppressive activity

  • Original articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

Incubation of human lymphocytes with recombinant interleukin-2 (rIL-2) results in the generation of lymphokine-activated killer (LAK) cells capable of lysing a wide variety of tumor cells. The present study was undertaken to examine the effect of recombinant γ interferon (rIFN-γ) on LAK cell cytotoxicity generated from different peripheral blood mononuclear cell (PBMC) subpopulations. When unseparated PBMC were stimulated by rIL-2 and rIFN-γ, the latter induced a transient enhancement after 2 days followed by a suppression of LAK cell cytotoxicity at day 6. Enhancement of LAK cell cytotoxicity was moderate and inconstant, whereas the inhibition was strong and observed with all the donors tested. This suppression was not associated with a decrease in the [3H]thymidine uptake. PBMC depleted of adherent cells were more sensitive to the stimulation by rIL-2 and the induced cytotoxicity was not modified by rIFN-γ. Monocyte-enriched plastic-adherent cells, when incubated with rIL-2 and rIFN-γ, became cytotoxic after 2–3 days of culture and inhibited LAK cell activity after 5–6 days. Collectively, our results suggest that rIFN-γ affects LAK cell cytotoxicity through the activation of plastic-adherent, monocyte-rich, cells which modulate natural killer cells, first in a positive, then in a negative way.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Billard C, Ferbus D, Kolb JP, Rosa F, Perrot JY, Merlin G, Janiaud P, Raynaud N, Thang MN, Fellous M, Aguet M, Fridman WH, Falcoff E (1986) Qualitative differences in effects of recombinant α-, β- and γ-interferons on human peripheral blood leukocytesin vitro. Ann Inst Pasteur Immunol 137: 259

    Google Scholar 

  2. Bloom ET, Babbitt JT (1985) Monocyte-mediated augmentation of human natural cell-mediated cytotoxicity. Cell Immunol 91: 21

    Google Scholar 

  3. Brunda MJ, Tarnowski D, Davatelis V (1986) Interaction of recombinant interferons with recombinant interleukin-2: differential effects on natural killer cell activity and interleukin-2 activated killer cells. Int J Cancer 37: 787

    Google Scholar 

  4. Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA (1982) Lymphokine-activated killer cell phenomenon. Lysis of Natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med 155: 1823

    Google Scholar 

  5. Handa K, Suzuki R, Matsui H, Shimizu Y, Kumagai K (1983) Natural killer (NK) cells as a responder to interleukin-2 (IL2). II. IL2-induced interferon γ production. J Immunol 130: 988

    Google Scholar 

  6. Heberman RB, Hiserodt J, Vujanovic N (1987) Lymphokineactivated killer cell activity. Characteristics of effector cells and their progenitors in blood and spleen. Immunol Today 8: 178

    Google Scholar 

  7. Herrmann F, Cannistra SA, Levine H, Griffin JD (1985) Expression of interleukin-2 receptors and binding of interleukin-2 by gamma interferon-induced human leukemic and normal monocytic cells. J Exp Med 162: 1111

    Google Scholar 

  8. Holter W, Grunow R, Stockinger H, Knapp W (1986) Recombinant interferon-γ induces interleukin-2 receptors on human peripheral blood monocytes. J Immunol 136: 2171

    Google Scholar 

  9. Hoyer M, Meineke T, Lewis W, Zwilling B, Rinehart J (1986) Characterization and modulation of human lymphokine (interleukin-2) activated killer cell induction. Cancer Res 46: 2834

    Google Scholar 

  10. Itoh K, Shiiba K, Shimizu Y, Suzuki R, Kumagai K (1985) Generation of activated killer (AK) cells by recombinant interleukin-2 (rIL-2) in collaboration with interferon-γ (IFN-γ). J Immunol 134: 3124

    Google Scholar 

  11. Koren HS, Anderson SJ, Fischer DG, Copeland CS, Jensen PJ (1981) Regulation of human natural killing. I. The role of monocytes, interferon and prostaglandins. J Immunol 127: 2007

    Google Scholar 

  12. Le J, Prensky W, Yip YK, Chang Z, Hoffman T, Stevenson HC, Balazs I, Sadlik JR, Vilcek J (1983) Activation of human monocyte cytotoxicity by natural and recombinant immune interferon. J Immunol 131: 2821

    Google Scholar 

  13. Malkovsky M, Loveland B, North M, Asherson GL, Gao L, Ward P, Fiers W (1987) Recombinant interleukin-2 directly augments the cytotoxicity of human monocytes. Nature 325: 262

    Google Scholar 

  14. Mazumder A, Rosenberg SA (1984) Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activatedin vitro by interleukin 2. J Exp Med 159: 495

    Google Scholar 

  15. Mazumder A, Agah R, Malloy B (1987) Interleukin 2 (IL2) synergizes with γ-interferon (IFN-γ) to generate LAK cellsin vitro andin vivo. AACR Proc Cancer Res 28: 365

    Google Scholar 

  16. Nedwin GE, Svedersky LP, Bringman TS, Palladino MA Jr and Goeddel DV (1985) Effect of interleukin 2, interferon-γ and mitogens on the production of tumor necrosis factors α and β. J Immunol 135: 2492

    Google Scholar 

  17. Nii A, Sone S, Utsugi T, Yanagawa H, Ogura T (1988) Upand down-regulation of human lymphokine (IL2)-activated killer cell induction by monocytes, depending on their functional state. Int J Cancer 41: 33

    Google Scholar 

  18. Oshimi K, Oshimi Y, Satake M, Mizoguchi H (1985) Natural killer-mediated lysis of normal and malignant target cells, and its regulation by monocytes. J Exp Med 162: 472

    Google Scholar 

  19. Ostensen ME, Thiele DL, Lipsky PE (1987) Tumor necrosis factor-α enhances cytolytic activity of human natural killer cells. J Immunol 138: 4185

    Google Scholar 

  20. Owen-Schaub LB, Gutterman JU, Grimm EA (1988) Synergy of tumor necrosis factor and interleukin-2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor α and interleukin-2 in the generation of human lymphokine-activated killer cell cytotoxicity. Cancer Res 48: 788

    Google Scholar 

  21. Rosenberg SA, Lotze MT (1986) Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes. Ann Rev Immunol 3: 681

    Google Scholar 

  22. Rosenberg SA, Lotze MT, Muul LM, Chang AE, Avis FP, Leitman S, Linehan WM, Robertson CN, Lee RE, Rubin JT, Seipp CA, Simpson CG, White DE (1987) A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med 316: 889

    Google Scholar 

  23. Sayers JT, Mason AT, Ortaldo JR (1986) Regulation of human natural killer cell activity by interferon-γ: lack of a role in interleukin 2-mediated augmentation. J Immunol 136: 2176

    Google Scholar 

  24. Sone S, Utsugi T, Nii A, Ogura T (1987) Effects of human alveolar macrophages on the induction of lymphokine (IL2)-activated killer cells. J Immunol 139: 29

    Google Scholar 

  25. Sone S, Utsugi T, Nii A, Ogura T (1988) Differential effects of recombinant interferons α, β and γ on induction of human lymphokine (IL2)-activated killer activity. J Natl Cancer Inst 80: 425

    Google Scholar 

  26. Svedersky LP, Shepard HM, Spencer SA, Shalaby MR, Palladino MA (1984) Augmentation of human natural cell-mediated cytotoxicity by recombinant human interleukin 2. J Immunol 133: 714

    Google Scholar 

  27. West WH, Tauer KW, Yannelli JR, Marshall GD, Orr DW, Thurman GB, Oldham RK (1987) Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer. N Engl J Med 316: 898

    Google Scholar 

Download references

Author information

Author notes

  1. Michel Toledano

    Present address: Cell Biology and Metabolism Branch, National Institute of Child Health and Human Development, National Institutes of Health, 20892, Bethesda, MD, USA

Authors and Affiliations

  1. Laboratoire d'Immunologie Cellulaire et Clinique (INSERM U.255), Institut Curie, 26 rue d'Ulm, F-75 231, Paris Cédex 05, France

    Michel Toledano, Claire Mathiot, Jean Michon & Wolf H. Fridman

  2. Laboratoire d'Hématologie, Institut Curie, 26 rue d'Ulm, F-75 231, Paris Cédex 05, France

    Claire Mathiot

  3. Hôtel Dieu, Centre de Transfusion Sanguine, 1 place du Parvis de Notre-Dame, F-75 181, Paris Cédex 04, France

    Georges Andreu

  4. Roussel-Uclaf, 102-111, Route de Noisy, F-93 230, Romainville, France

    Danielle Lando & Maud Brandely

Authors
  1. Michel Toledano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claire Mathiot
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jean Michon
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Georges Andreu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Danielle Lando
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Maud Brandely
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Wolf H. Fridman
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Toledano, M., Mathiot, C., Michon, J. et al. Interferon-γ (IFN-γ) and interleukin-2 in the generation of lymphokine-activated killer cell cytotoxicity — IFN-γ-induced suppressive activity. Cancer Immunol Immunother 30, 57–64 (1989). https://doi.org/10.1007/BF01665031

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01665031

Keywords

Search

Navigation